CDNA (CareDx, Inc.) - Bullish end to the Quarter
CDNA
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Shaky start to the first half of the quarter
- Room for a return to at least the LOW point
- Trailing stop-loss on price above LOW point
GOOD LUCK.
DO YOUR OWN RESEARCH!
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Shaky start to the first half of the quarter
- Room for a return to at least the LOW point
- Trailing stop-loss on price above LOW point
GOOD LUCK.
DO YOUR OWN RESEARCH!
Exit trade for profits prior to earnings call